Search Results (147)

Antimicrobial resistance in bovine mastitis pathogens poses interconnected threats to dairy productivity and public health; however, longitudinal evidence on the association between veterinary oversight and lower resistance to critically important antimicrobials in tropical smallholder systems remains limited. This study analyzed 1347 quarter milk samples from 47 dairy farms in Saraburi Province, Thailand, submitted consecutively over five years (2020–2025), to evaluate whether participation in a veterinary-led herd health (HH) program was independently associated with reduced vancomycin resistance and multidrug resistance (MDR). Bacterial identification was conducted using standard methods, and susceptibility was determined using the Kirby–Bauer disk diffusion method. Among 1069 culture-positive samples, Streptococcus spp. (25.3%) and coagulase-negative staphylococci (16.8%) predominated. Vancomycin resistance declined from 15.9% to 5.4% between early (2020–2022) and recent (2023–2025) periods. Of the 686 isolates tested against ≥3 antibiotic classes, 61 (8.9%) were MDR; vancomycin resistance co-occurred in 34.4% of these samples. Repeated logistic regression identified non-HH farm status (OR = 4.035; p = 0.027) and early-year groups (OR = 4.611; p = 0.002) as independent risk factors for vancomycin resistance. As HH participation and year group showed a significant interaction, their joint effect for MDR was modeled: compared with non-HH farms in the early period (reference), all other combinations—including HH farms in 2023, HH farms in 2020, and non-HH farms in 2023—were associated with significantly lower odds of MDR. These findings provide the first evidence from Thailand that structured veterinary herd health programs are independently associated with lower critically important antimicrobial resistance, supporting their integration into a One-Health stewardship policy. Full article

Background: Infection following total knee arthroplasty (TKA) is a challenging complication. Optimal empirical antibiotic therapy and surgical management hinge on up-to-date knowledge of local pathogen distribution and resistance patterns. However, few studies have examined whether geographical factors, specifically rural versus urban residence, influence the microbiology or clinical outcomes of periprosthetic joint infection (PJI) within integrated healthcare systems. The goal of this study was to assess the temporal evolution of bacterial species and antimicrobial resistance in knee PJI over an 11-year period. As a secondary objective, we wanted to evaluate the potential impact of patient residence on microbiological trends and treatment success. Methods: We conducted a retrospective analysis of all patients diagnosed with knee PJI who underwent surgical treatment between 2013 and 2023 at our center. Infections were classified as acute postoperative, acute hematogenous, or chronic. Patient residence was categorized as rural (<5000 inhabitants) or urban. Temporal trends were modeled using Poisson regression, and comparisons between subgroups were performed using Fisher’s exact test and Student’s t-test. Results: A total of 98 patients were analyzed, with 99 microorganisms identified. Gram-positive organisms predominated (72.3%), with Staphylococcus aureus (33.3%) and Coagulase-negative Staphylococci (CoNS) (29.3%) as the most frequent isolates. Resistance to vancomycin was not detected in S. aureus isolates. However, CoNS demonstrated high resistance to fluoroquinolones (55.2%) and rifampicin (20.7%). No significant annual shifts were observed for Gram-positive (IRR = 0.94; 95% CI: 0.86–1.03; p = 0.413) or Gram-negative cases (IRR = 0.75; 95% CI: 0.53–1.05; p = 0.086). Comparing rural versus urban populations, no differences were found in microbiological profiles (Fisher’s exact test, all p > 0.05). Furthermore, clinical treatment success rates were comparable (Rural 69.4% vs. Urban 63.0%, p = 0.500), despite a significantly higher prevalence of diabetes mellitus in rural patients (34.7% vs. 10.2%, p = 0.007). Conclusions: The microbiological landscape of knee PJI has remained stable, with no emergence of multidrug-resistant S. aureus. In our setting, standardized management protocols appeared to be equally effective regardless of patient residence. However, given the single-center nature and sample size of this study, broader multicenter validation is required before these findings can be generalized. Full article

Introduction: Bacterial multidrug resistance (MDR) drives treatment with expensive, toxic, or pharmacokinetically suboptimal antibiotics. Objectives: To assess the prevalence of MDR Gram-positive cocci among isolates from cardiac implantable electronic device (CIED) infections at a Polish reference center. Methods: Data come from the “EXTRACT” registry (ClinicalTrials.gov ID NCT05775783), which covers 702 transvenous lead extraction procedures. Blood samples and intraoperative swabs were collected from participants with CIED infection. Results: From 209 cases with isolated pocket infection (PI) (107, 51.2%) or systemic infections (102, 48.8%), 263 Gram-positive cocci were cultured. They were: coagulase-negative staphylococci (CoNS) (177, 67.3%), Staphylococcus aureus (62, 23.6%), enterococci (15, 5.7%), streptococci (8, 3.0%), and others (1, 0.4%). The highest MDR rate was among CoNS (46.9%). CoNS exhibited methicillin resistance (MR-CoNS) in 55.9% with co-resistance to macrolides (73.2%), lincosamides (51.0%), fluoroquinolones (56.1%), aminoglycosides (41.4%), tetracyclines (29.6%), and co-trimoxazole (29.3%). Resistance to daptomycin (5.3%) and linezolid (2.0%) in MR-CoNS was rare. The frequency of MDR S. aureus was 8.1%. Methicillin resistance in S. aureus (MRSA, 6.5%) co-occurred with resistance to macrolides/lincosamides and fluoroquinolones (100% for both) or linezolid (25.0%). All MDR staphylococci were vancomycin-susceptible. High-level aminoglycoside resistance (HLAR) in Enterococcus faecalis (53.8%) was accompanied by levofloxacin co-resistance (66.7%). Conversely, E. faecium HLAR (50.0%) strains showed 100.0% β-lactam resistance. Vancomycin-resistant enterococci (VRE) accounted for 6.7%; the VRE E. faecium strain was tigecycline- and linezolid-susceptible. Among viridans group streptococci, β-lactam and lincosamides resistance was common (40.0% for both), with 50.0% of co-resistance. Conclusions: Epidemiological data may improve the effectiveness of empirical antibiotic therapy for CIED-related infections. Full article

Background: Periprosthetic joint infection (PJI) is a severe complication following megaprosthetic reconstruction in musculoskeletal oncology. This study aimed to evaluate outcomes of different surgical strategies for PJI in lower-limb megaprostheses and identify factors associated with treatment failure. Methods: We performed a retrospective cohort study of 29 consecutive patients treated for PJI after oncologic megaprosthetic reconstruction. Reinfection was analyzed using cumulative incidence functions (CIFs) with death treated as a competing event. Overall survival was assessed using Kaplan–Meier analysis. Univariable cause-specific Cox regression was performed for exploratory risk-factor analysis. Results: Among 29 patients, coagulase-negative staphylococci and Staphylococcus aureus were the most frequently isolated pathogens, and difficult-to-treat organisms were identified in a substantial proportion of cases. In patients managed with two-stage revision, the cumulative incidence of reinfection was 15% (95% CI: 0–30%) at 1 year and 30% (95% CI: 10–50%) at 2 and 5 years. In the DAIR cohort, the cumulative incidence of reinfection was 25% (95% CI: 0–62.5%) at 1 and 2 years and 37.5% (95% CI: 12.2–75%) at 3 years. Positive reimplantation cultures occurred in 38% of cases and were strongly associated with subsequent treatment failure. Polymicrobial infections were present in 27.5% of cases. Amputation was required in 17.2% of patients, often due to multidrug-resistant organisms or poor soft tissue. Conclusions: Two-stage revision remains the most effective strategy for PJI management in megaprostheses. DAIR may control acute infection but is suboptimal for definitive treatment. Individualized, multidisciplinary approaches are essential to improve outcomes in this high-risk population. Full article

Background/Objectives: Recent investigations point to red foxes (Vulpes vulpes) as a very potent sentinel species for monitoring the dissemination of antimicrobial bacteria in wildlife habitats. Methods: This study investigated antimicrobial resistance in red foxes from 16 hunting grounds (peri-urban and peri-rural) in western Romania, between 2022 and 2024, in order to evaluate the species as “One Health” sentinels at the wildlife–human–animal interface. During this period, 137 bacterial strains previously identified from 216 samples were phenotypically tested using both the Kirby–Bauer disk diffusion method and the Vitek 2 Compact system. Results: Among the Gram-negative isolates, particularly Escherichia coli and Salmonella enterica, notable antimicrobial resistance and multidrug-resistant (MDR) phenotypes were observed, including resistance to third-generation cephalosporins (ceftazidime) and reduced susceptibility to carbapenems. Resistance patterns observed in Proteus spp. largely reflected intrinsic resistance traits. Methicillin-resistant and MDR staphylococci (Staphylococcus aureus, S. pseudintermedius and S. sciuri) were detected in both peri-urban and peri-rural hunting grounds, with higher frequencies observed in peri-rural areas. Although MDR prevalence was slightly higher in peri-urban compared to peri-rural sites, no statistically significant association was identified between area of isolation and antimicrobial resistance or MDR status. Antimicrobial susceptibility results obtained by disk diffusion and the Vitek 2 Compact system showed a high level of concordance for antibiotics tested in common. Conclusions: Overall, these findings support the use of red foxes as effective One Health sentinels for monitoring environmental antimicrobial resistance occurrence across wildlife, domestic animals, and human-impacted habitats. Full article

Background/Objectives: Reverse total shoulder arthroplasty (RTSA), a commonly performed procedure in elderly patients with osteoarthritis, is frequently complicated by postoperative infections—primarily caused by Cutibacterium acnes and coagulase-negative staphylococci (CoNS)—which remain a major clinical challenge. While standard antiseptic skin protocols can reduce the bacterial load at the surgical site, they often fail to achieve complete eradication, particularly with C. acnes, a resident species of the shoulder microbiome. Recent evidence indicates that intraoperative povidone–iodine irrigation is effective in significantly decreasing microbial burden; however, a thorough characterization of the virulence factors of the isolated strains remains essential. Methods: A total of 187 clinical strains isolated immediately after RTSA were characterized with respect to their antibiotic resistance profiles and biofilm-forming capacity, and the impact of intraoperative povidone–iodine irrigation on the reduction in bacteria that express these virulence traits was evaluated. Results: Of the 120 C. acnes isolates, 97.67% were susceptible to the tested antimicrobial agents, while only 3.33% exhibited resistance, specifically to clindamycin. In contrast, 53% of CoNS isolates were classified as susceptible, whereas the remaining 47% demonstrated multidrug resistance. Biofilm production was detected in 24% (29/120) of C. acnes and 39% (25/64) of CoNS isolates, with a statistically significant reduction observed after irrigation only for C. acnes. No association was found between biofilm formation and clindamycin resistance in C. acnes, likely due to the low number of resistant isolates. Conversely, among CoNS, a correlation was observed, with the 17.2% of biofilm-producing strains also exhibiting resistance to antimicrobial agents. Conclusions: Notwithstanding the presence of these virulence factors, povidone–iodine irrigation proved effective in substantially reducing the number of bacterial isolates recovered at the surgical site without selecting for strains with enhanced pathogenicity. Notably, the majority of resistant bacteria were detected prior to intraoperative irrigation. This intraoperative procedure may be a key approach to reducing prosthetic joint infections frequently caused by more virulent pathogens, which are unlikely to be selected following this disinfection strategy. Full article

Fusidic acid resistance in Staphylococcus spp. has historically been confined to Staphylococcus ureilyticus, with limited data on its environmental distribution. This study presents the first detection of the fusidic acid resistance gene fusF in Staphylococcus kloosii recovered from virgin soil at Kampung Batu 16, Dusun Tua, Hulu Langat, Malaysia. A total of ten Staphylococcus isolates were identified using the VITEK^®2 system with high confidence (97–99%), comprising seven S. kloosii and three S. ureilyticus. Sequencing of representative isolates further corroborated the species identification. All isolates displayed phenotypic resistance to fusidic acid, while all S. ureilyticus (3/3) exhibited multi-drug resistant (MDR) traits and S. kloosii (7/7) exhibited non-MDR traits. PCR and sequencing confirmed the presence of fusF gene in S. ureilyticus (3/3) and S. kloosii (3/7). In addition, fusB and fusC genes were not detected in both species. The phylogenetic analysis (Maximum Likelihood, Tamura–Nei model) revealed high sequence conservation and clustering between fusF-positive S. kloosii and S. ureilyticus soil isolates, suggesting recent horizontal gene transfer between these two related species. The first detection of fusF gene in S. kloosii from virgin soil signifies the expansion of the ecological and host range beyond S. ureilyticus, establishes virgin soil as a potential antimicrobial resistance (AMR) reservoir, and underscores the One Health risks of resistance dissemination from environmental staphylococci. This baseline study highlights the importance of early AMR surveillance in tropical environments prior to agricultural development. Full article

Background: Canine skin and ear infections are common in small-animal practice and increasingly complicated by multidrug resistance (MDR), yet data from Serbia are limited. This study aimed to describe the bacterial etiology and antimicrobial resistance patterns in canine otitis externa and pyoderma. Methods: We retrospectively reviewed laboratory records from the Clinical Bacteriology and Mycology Laboratory, Faculty of Veterinary Medicine, University of Belgrade (January 2017–August 2024). A total of 422 non-invasive swabs from clinically ill dogs were included (ears: n = 210; skin: n = 212). Bacterial identification used conventional methods and commercial systems, and disk-diffusion susceptibility testing followed CLSI/EUCAST guidance. Methicillin resistance in staphylococci was assessed by cefoxitin/oxacillin screening; MRSA was confirmed by PCR and PBP2a detection. Resistance trends were compared between 2017–2020 and 2021–2024. Results: The leading pathogens were Staphylococcus pseudintermedius (ears 48.1%; skin 79.7%) and Pseudomonas aeruginosa (ears 29.1%; skin 7.6%). Staphylococci showed high resistance to macrolides, clindamycin, tetracycline, and first-line β-lactams (amoxicillin–clavulanate, cephalexin), with the highest susceptibilities to amikacin, florfenicol, and rifampicin. P. aeruginosa remained most susceptible to amikacin, polymyxin B, and imipenem. Between the two periods, S. pseudintermedius resistance increased to amikacin, fusidic acid, and cephalexin, while resistance to florfenicol decreased. P. aeruginosa resistance to imipenem increased. The prevalence of methicillin-resistant S. pseudintermedius (MRSP) was 27.4% (74/270). MDR S. pseudintermedius and MDR P. aeruginosa were identified in 38.5% and 53.3% of isolates, respectively. One isolate of each species was resistant to all tested drugs. Conclusions: These findings confirm high levels of antimicrobial resistance in major canine skin and ear pathogens and emphasize the need for susceptibility-based therapy, rational antimicrobial use, and ongoing surveillance in small-animal practice. Full article

Wastewater-based surveillance (WBS) is valuable for monitoring antimicrobial resistance (AMR). Staphylococci are key targets, as wastewater can facilitate gene transfer and resistance emergence. Data on WBS for population-level AMR in the Arabian-Gulf remain limited. This study assessed Staphylococcus diversity and resistance in Dubai wastewater. Samples were collected over eight months from nine community sites, two hospital nodes, and two wastewater treatment plants (WWTPs) and were analysed by culture-based method. Ninety-six Staphylococcus isolates were recovered from community, hospital, and WWTP influent, with no growth in effluent. Most isolates (n/N = 88/96) were coagulase-negative Staphylococcus (CoNS), spanning 15 species, dominated by S. saprophyticus, S. cohnii and S. sciuri. The only coagulase-positive Staphylococcus was S. aureus (n = 8) and the only species detected across all wastewater sources. Resistance was highest to benzylpenicillin (88%) and fusidic acid (82%), whereas all isolates remained susceptible to glycopeptides, tigecycline, and linezolid. Fusidic acid resistance was higher in community-wastewater isolates, whereas β-lactam resistance predominated in hospital-wastewater isolates. Sixty percent of CoNS were multidrug-resistant; methicillin resistance occurred in 37.5% of CoNS and 50% of S. aureus. Wastewater is a reservoir of diverse multidrug-resistant staphylococci, underscoring One Health relevance reflecting the potential for circulation between humans, animals, and the shared environment. WBS can support population-level AMR monitoring to inform public health and veterinary interventions. Full article

This study evaluated the microbiological quality, presence of virulence genes, and antimicrobial resistance of Staphylococcus aureus and Escherichia coli in sheep and goat milk and traditional Romanian dairy products (Telemea and Burduf cheeses). Raw milk contained high levels of coagulase-positive staphylococci (CPS; 5.2 log CFU/mL) and E. coli (4.3 log CFU/mL), with several samples exceeding legal limits. Sour cream exhibited moderate CPS (1.2–1.9 log CFU/g) and E. coli (0.4–3.12 log CFU/g) counts, with occasional non-compliance. Cheeses had low CPS (0.52–0.84 log CFU/g) and E. coli (0.37–0.89 log CFU/g) levels, all within permissible limits. Molecular analysis detected the nuc gene in 21 sheep milk samples, of which 85.7% also carried the sea gene and 14.3% carried seb. Additionally, two goat milk samples tested positive for both nuc and sea. Three Telemea cheese samples were also sea-positive. Among raw milk samples, 10 E. coli isolates carried stx1, and two additionally harbored hly, while dairy products were negative for E. coli virulence genes. Antimicrobial susceptibility testing showed high resistance of S. aureus to penicillin (90.5%) and ampicillin (85.7%), with multidrug resistance among sea- and seb-positive isolates. STEC isolates showed resistance to ampicillin (70%), tetracycline (50%), and trimethoprim–sulfamethoxazole (40%), but remained susceptible to amoxicillin–clavulanic acid. Full article

Osteoarticular infections (OAIs), including osteomyelitis, septic arthritis, prosthetic joint infections, and facture-related infections, remain a major challenge due to biofilm formation and the prevalence of multidrug-resistant (MDR) pathogens. Although OAIs are predominantly caused by Staphylococcus aureus and coagulase-negative staphylococci, the increasing incidence of MDR Gram-negative infections adds further complexity to their management. Standard approaches, combining surgery and prolonged antibiotic therapy, frequently result in recurrence and poor outcomes. Bacteriophage (phage) therapy has emerged as a promising adjunct or alternative approach, offering high host specificity, replication at the infection site, and activity against biofilm-embedded bacteria. This review highlights recent advances in phage therapy for OAIs, focusing on administration routes (intravenous, intra-articular, topical, and oral) and on novel pharmaceutical delivery systems such as hydrogels, bone cements, microparticles, nanoparticles, and implant coatings. Preclinical and early clinical studies have analyzed phage stability, controlled release, and the synergistic effects of combined phage/antibiotic therapy. However, challenges remain regarding standardization, immunogenicity, and regulatory approval. Nonetheless, phage therapy shows promise for clinical translation as an adjunct or alternative to conventional treatments for OAIs. Well-designed clinical trials are urgently needed to confirm the efficacy of phage therapy, optimize delivery strategies, and integrate the treatments in routine practice. Despite encouraging outcomes for a successful clinical implementation, regulation and standardization of GMP production are required. Full article

Antimicrobial resistance (AMR) is a growing global health concern with profound implications for ophthalmology, where it compromises the management of ocular infections such as bacterial keratitis, conjunctivitis, endophthalmitis, and postoperative complications. Resistance in common ocular pathogens, including Staphylococcus aureus (S. aureus), Streptococcus pneumoniae (S. pneumoniae), Pseudomonas aeruginosa (P. aeruginosa), and coagulase-negative staphylococci (CoNS) emerge through genetic mutations, horizontal gene transfer, and biochemical mechanisms such as enzymatic degradation, target modification, efflux pumps, and reduced membrane permeability. Biofilm formation further complicates eradication on the ocular surface and interior. The key drivers of resistance include inappropriate or prolonged topical antibiotic use, routine prophylaxis in ocular surgery, subtherapeutic dosing, and cross-resistance with systemic antimicrobials. The rise in multidrug-resistant strains, particularly methicillin-resistant S. aureus, fluoroquinolone-resistant P. aeruginosa, and drug-resistant S. pneumoniae has been linked to delayed treatment response, increased healthcare costs, and sight-threatening outcomes. Recent advances in rapid diagnostics, molecular assays, and point-of-care testing support earlier and more precise detection of resistance, enabling timely therapeutic decisions. Promising strategies to address AMR in ophthalmology include antimicrobial stewardship, novel drug delivery platforms, and alternative approaches such as bacteriophage therapy and antimicrobial peptides. Emerging tools, including genomic surveillance, artificial intelligence (AI)-driven resistance prediction, and personalized antimicrobial regimens, further expand opportunities for innovation. Collectively, this review synthesizes current evidence on AMR in ocular disease, summarizing patterns of resistance, underlying mechanisms, and clinical consequences, while highlighting strategies for mitigation and underscoring the need for global awareness and collaboration among clinicians, researchers, and policymakers to safeguard vision. Full article

Recently published halogenated anilides of chlorinated and trifluorinated cinnamic acids, such as (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-(3,4-dichlorophenyl)prop-2-enamide, (2E)-N-(3,5-dichlorophenyl)-3-[3-(trifluoromethyl)phenyl]prop-2-enamide, or (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide, showed excellent antibacterial activities in vitro against Gram-positive bacteria, especially against reference and quality control strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212, as well as against representatives of multidrug-resistant bacteria, clinical isolates of methicillin-resistant S. aureus (MRSA), and vancomycin-resistant E. faecalis (VRE) with minimum inhibitory concentrations (MICs) against staphylococci < 0.2 µg/mL and against enterococci < 4 µg/mL. It should be noted that all these compounds are rather lipophilic (software predicted log P values close to 5) and carry electron-withdrawing substituents that allow them to be classified as so-called Michael acceptors. All these facts inspired further investigation of the spectrum of effectiveness against other bacteria, and the most effective agents with various substitutions in both the anilide part and on the phenyl ring of the parent cinnamic acid were chosen and tested against selected pathogenic Gram-negative bacteria, such as reference and quality control strains Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27859, and a clinical isolate of Klebsiella pneumoniae 797. Unfortunately, it was found that none of the selected halogenated anilide derivatives with such high potency against Gram-positive bacteria demonstrated better efficacy against the tested Gram-negative bacteria than a MIC of 256 µg/mL. Full article

Background/Objectives: This study aimed to determine bacteria that grow in spontaneous ascites infection and their antibiotic susceptibility. Materials and Methods: A total of 291 cases of cirrhosis-related ascites were retrospectively analyzed between January 2007 and September 2015. Simple ascites, spontaneous ascites infection, spontaneous bacterial peritonitis, and culture results were recorded. Due to increasing antibiotic resistance, theoretically appropriate antibiotics were paired, and their susceptibility was evaluated in order to review our empirical antibiotic choices and evaluate new empirical treatment options. Results: In all cultures, 48.1% were Gram-positive cocci and 50.6% were Gram-negative bacilli. Multidrug-resistant bacteria grew in 16 cultures (22.2%). The most common bacterium was Escherichia coli, and the second most common bacteria were coagulase-negative staphylococci (CoNS). According to all culture data, the rate of antibiotic susceptibility was third- and fourth-generation cephalosporins between 76.4 and 68%, 68% for ampicillin-sulbactam, 81.8% for piperacillin-tazobactam, 66% for ciprofloxacin, 71% for levofloxacin, 30% for tetracycline, and 45% for penicillin. Beta-lactam group antibiotic susceptibility of CoNS was 25% for penicillin and 53% for ampicillin-sulbactam; 52% had methicillin resistance. The rate of resistance to quinolones was 35%. Multidrug resistance was detected in 40% of CoNS (eight cases). When theoretically appropriate antibiotics were paired, combination therapy increased the susceptibility rates. Conclusions: The increase in Gram-positive infections and resistance to other antibiotic groups indicates empirical antibiotic selection based on local microbial culture results and antibiotic susceptibility. Our results are crucial to allowing for more rational and successful use of antibiotics. Full article

Staphylococcus spp. are potential pathogens classified into more than 50 species, frequently presenting antimicrobial resistance (AMR) to several drugs. The present study aimed to identify the Staphylococcus species and their AMR in staphylococci isolated from healthy companion animals (pets) in southern Brazil. A total of 78 presumptive Staphylococcus sp. isolates (from 48 dogs and 30 cats) were obtained in a period of five years (2018–2022). All isolates were analyzed by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-ToF) and tested with a panel of antimicrobials frequently used in pet treatment in Brazil. The results demonstrated that 68 isolates were identified as Staphylococcus spp., including 26 (38.2%) classified as coagulase-positive staphylococci (CoPS) and 42 (61.8%) as coagulase-negative staphylococci (CoNS). CoPS included S. pseudintermedius (n = 20; 29.4%), S. aureus (n = 3; 4.4%), and S. schleiferi (n = 2; 2.9%), while CoNS were S. equorum (n = 12; 17.6%), S. felis (n = 7; 10.3%), S. sciuri (n = 8; 11.8%), S. simulans (n = 4; 5.9%), S. epidermidis (n = 1; 1.5%), S. haemolyticus (n = 1; 1.5%), S. saprophyticus (n = 1; 1.5%), and S. xylosus (n = 1; 1.5%). The remaining eight isolates were identified as Staphylococcus spp. AMR analyses demonstrated that 17 (25%) isolates presented susceptibility to all tested drugs, and 51 (75%) to one or more antimicrobials. Twenty-four (35.6%) isolates were multidrug resistant (MDR), and 13 (19.1%) were methicillin-resistant staphylococci (MRS). S. pseudintermedius was the CoPS most frequently with AMR, including nine (45%) MDR and four (20%) MRS, while S. equorum was the predominant CoNS with AMR, highlighting nine (75%) MDR and four (33.3%) MRS. The Staphylococcus species diversity identified here highlights the importance of studying the microorganisms circulating in healthy companion animals and their characteristics concerning pathogenicity and AMR. Full article